Skip to Content
Merck

Skip To

20780

Butyrylcholine iodide

≥99.0% (AT)

Synonym(s):

(2-Hydroxyethyl)trimethylammonium iodide butyrate

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View
Pack SizeSKUAvailabilityPrice

About This Item

Linear Formula:
CH3CH2CH2COOCH2CH2N(I)(CH3)3
CAS Number:
Molecular Weight:
301.17
UNSPSC Code:
12352204
NACRES:
NA.83
PubChem Substance ID:
EC Number:
219-666-0
Beilstein/REAXYS Number:
3917649
MDL number:
Pricing and availability is not currently available.
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist


Quality Level

assay

≥99.0% (AT)

form

powder

mp

85-89 °C

solubility

methanol: 1 g/10 mL, clear, colorless

storage temp.

2-8°C

SMILES string

[I-].CCCC(=O)OCC[N+](C)(C)C

InChI

1S/C9H20NO2.HI/c1-5-6-9(11)12-8-7-10(2,3)4;/h5-8H2,1-4H3;1H/q+1;/p-1

InChI key

GALNBQVDMJRFGJ-UHFFFAOYSA-M

Other Notes

Substrate for cholinesterase (EC 3.1.1.8)[1]; and acetylcholinesterase (EC 3.1.1.7)[2]


pictograms

Exclamation mark

signalword

Warning

Hazard Classifications

Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3

target_organs

Respiratory system

Storage Class

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

dust mask type N95 (US), Eyeshields, Gloves



Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library



Monitoring of air and water for enzyme inhibitors.
L H Goodson et al.
Methods in enzymology, 44, 647-658 (1976-01-01)
Vibhor Gupta et al.
PloS one, 14(11), e0225188-e0225188 (2019-11-26)
Rare diseases defined by genetic mutations are classic targets for gene therapy. More recently, researchers expanded the use of gene therapy in non-clinical studies to infectious diseases through the delivery of vectorized antibodies to well-defined antigens. Here, we further extend
Anaïs Barré et al.
Molecules (Basel, Switzerland), 24(7) (2019-04-04)
Despite their side effects, cholinesterase (ChE) inhibitors remain the only approved drugs to treat Alzheimer's disease patients, along with the N-methyl-d-aspartate (NMDA) receptor antagonist memantine. In the last few years, the dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) has also been



Questions

Reviews

No rating value

Active Filters